Alnylam Pharmaceuticals | Lånekapital

Loan Capital Endring Dato
Acadia Pharmaceuticals USD 0 0 2022-06
Agios Pharmaceuticals USD 1.06M 0 2022-09
Alnylam Pharmaceuticals USD 1.02B 956K 2024-03
Amgen USD 60.06B 3.11B 2024-03
Avrobio USD 15.36M 80K 2023-03
BioMarin Pharmaceutical USD 593.6M 510K 2024-03
Ionis Pharmaceuticals USD 1.23B 1.43M 2024-03
Neurocrine Biosciences USD 169.5M 500K 2023-03
Novartis USD 17.19B 2.84B 2024-03
PTC Therapeutics USD 284.51M 1.64B 2024-03
Regeneron Pharmaceuticals USD 1.98B 719.6M 2024-03
Sarepta Therapeutics USD 1.13B 103.1M 2024-03
Takeda JPY 4.29T 110.49B 2023-12
Ultragenyx Pharmaceutical USD 0 0 2022-06
Xencor USD 12.49M 2.15M 2024-03



Alnylam Pharmaceuticals Lånekapital - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.